# POTASSIUM CHLORIDE
> **ANDA216321** · Abbreviated New Drug Application (Generic) · Sponsor: RUBICON RESEARCH · Approved 2023-06-16
## Drug
- **FDA Application Number:** ANDA216321
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** POTASSIUM CHLORIDE
- **Generic name:** POTASSIUM CHLORIDE
- **Active ingredients:** POTASSIUM CHLORIDE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** RUBICON RESEARCH
- **Manufacturer:** Advagen Pharma Ltd.
- **First approval:** 2023-06-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216321)
---
*AI Analytics · CC0 1.0*